Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Minority Interest (2020 - 2025)

Historic Minority Interest for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $186.4 million.

  • Maravai Lifesciences Holdings' Minority Interest fell 3039.01% to $186.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $186.4 million, marking a year-over-year decrease of 3039.01%. This contributed to the annual value of $251.9 million for FY2024, which is 3248.56% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Minority Interest of $186.4 million as of Q3 2025, which was down 3039.01% from $202.1 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Minority Interest registered a high of $379.1 million during Q1 2023, and its lowest value of $97.1 million during Q1 2021.
  • Moreover, its 5-year median value for Minority Interest was $271.7 million (2022), whereas its average is $276.3 million.
  • In the last 5 years, Maravai Lifesciences Holdings' Minority Interest skyrocketed by 24704.01% in 2021 and then tumbled by 4015.7% in 2025.
  • Quarter analysis of 5 years shows Maravai Lifesciences Holdings' Minority Interest stood at $229.9 million in 2021, then soared by 56.63% to $360.0 million in 2022, then increased by 3.64% to $373.1 million in 2023, then tumbled by 32.49% to $251.9 million in 2024, then dropped by 26.0% to $186.4 million in 2025.
  • Its last three reported values are $186.4 million in Q3 2025, $202.1 million for Q2 2025, and $229.7 million during Q1 2025.